C. Chang | lit.salon

Explore Salon Quotes Lists Reviews Writings

—

Changelog About Contact Privacy Donate

C. Chang | lit.salon

C. Chang

No bio available. Add one in Open Library.

Books by C. Chang (50 max)

Q and A Law of Evidence: Blackstone's Law Questions and Answers (Blackstone Law Questions and Answers)

1996

Chris Chang, M. Spencer, C. Chang

Biology and biotechnology of the plant hormone ethylene

1997

C. Chang, Donald Grierson

Biology and biotechnology of the plant hormone ethylene II

1999

C. Chang, Donald Grierson, H. Klee

Symbolic logic and mechanical theorem proving

1973

Advances in Plant Ethylene Research: Proceedings of the 7th International Symposium on the Plant Hormone Ethylene

2007

C. Chang, H. Klee

Biology and Biotechnology of the Plant Hormone Ethylene Ii

2012

A.K. Kanellis, C. Chang, H. Klee

Special Issue on Innovative Applications of Data Envelopment Analysis to Accounting and Finance

2013

C. Chang, Ehsan Feroz, Janis Zaima

Violations of 21 CFR Part 803 - Medical Device Reporting: Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 - Quality System Regulation, Subpart G Production and Process Controls: Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 - Quality System Regulation, Subpart M Records Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 Quality System Regulation, Subparts d-F : Document Controls, Purchasing Controls, Identification and Traceability: Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 Quality System Regulation, Subparts H-I : Acceptance Activities and Nonconforming Product Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 - Quality System Regulation, Subpart J Corrective and Preventive Action Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 820 - Quality System Regulation, Subpart C Design Controls Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 56 - Institutional Review Boards: Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U. S. Food and Drug Administration

2015

Violations of 21 CFR Part 806 - Medical Devices; Reports of Corrections and Removals: Warning Letters Issued by U. S. Food and Drug Administration

2015

Mummy Works in Human Resources

2020